Table 3.
Characterization of other nanoparticles.
| Investigators | Nanoplatform | Average Particle Size (nm) (±S.D.) | Zeta Potential (mV) (±S.D.) |
PDI | Photosensitizer |
|---|---|---|---|---|---|
| Ke et al. [153] | IrS NPs ** | 84 ± (4) | 21.6 ± (0.9) | -- | IrIII complex |
| Zhong et al. [166] | Au NRs/Cur/UCNPs@PBE | 114.13 ± (3.21) | 12.67 ± (1.2) | 0.342 | Curcumin |
| Wang et al. [157] | MH-PLGA-IR780 NPs | 236.8 | −10.09 ± (0.70) | -- | IR780 |
| Zhao et al. [158] | C-ML162(ML162:Ce6 = 3:1) | 140.1 ± (4.3) | ~−25 | 0.223 ± (0.016) | Ce6 |
| Yang et al. [165] | HA@MR@PCN-CORM | 215 | −20.8 | 0.085 | PCN-224 |
| Wang et al. [164] | BSO-MOF-HA | 162.5 | −25.5 | -- | MOF |
| Ding et al. [170] | MSP@ART@ P | ~70 | −13.6 | 0.061 | ICG |
| Yu et al. [169] | C– N– Ce6 ** | 172.7 ± (4.9) | 32.4 ± (1.0) | 0.268 ± (0.011) | Ce6 |
| Li et al. [168] | 5-Fu⊂nano DSPP-COF | 77 | ~ −15 | 0.181 | TFPP |
| Song et al. [159] | BNP@R ** | <100 | -- | <0.2 | Pheophorbide a |
| Zhu et al. [9] | Ce6-erastin NPs | 100 ± (20) | -- | -- | Ce6 |
| Tao et al. [160] | BSMCPF ** | -- | -- | 0.207 | Ce6 |
| Meng et al. [162] | Ce6@RMOF ** | -- | -- | -- | Ce6 |
| Tian et al. [156] | HL/MOS@M780&LOD NPs | -- | −15 | -- | Mitochondria-targeted IR780 |
| Liao et al. [167] | Au@Chl/Fe-CPBA nanorods |
-- | -- | -- | Iron chlorophyll |
** IrS NPs: IrIII complex nanoparticles; C– N– Ce6: p-nitrobenzyl chloroformate, chitosan, Ce6; BNP@R: PDPA and PDBA@ RSL-3; BSMCPF: brusatol/silica@MnO2/Ce6@PDA-PEG-FA; Ce6@RMOF: Ce6@glutathione-responsive metal organic framework.